In line with the observation suggesting that PRL/STAT5 is important for cancer initiation but not for tumor progression [102], Peck et al. showed that levels of nuclear phosphorylated STAT5 are significantly higher in ductal carcinoma in situ than in cases of invasive and metastatic disease. The gene discussed is STAT5A; the disease is neoplasm.